Saturday, November 07, 2026 11:26 AM ET
1 day ago
CVS Health plans to split itself up. Here's why a breakup could make sense now2 days ago
Jim Cramer says this bank stock is a buy after its post-election pullback2 days ago
CVS falls on plans to split off drugstore business in major breakup2 days ago
Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook3 days ago
Pfizer hikes 2026 outlook as new products grow, taps company veteran as new CFO3 days ago
Midterm elections could jolt stocks as Democrats look poised to sweep Congress3 days ago
A biotech's high-stakes cancer bet just paid off and its shares doubled4 days ago
Jim Cramer says lower oil prices are giving stocks a boost. Can it last?4 days ago
Stocks started the week higher but ended in despair. Our take on the big reversal4 days ago
Cramer's week ahead: Expect more volatility as tech earnings, midterms loom7 days ago
Gen Z is ditching bars for run clubs — and finding more than friends along the way8 days ago
A pharma major is touting an MS drug to ease patent-cliff fears8 days ago
West Pharma: More than a GLP-1 play. The case for further upside8 days ago
Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx8 days ago
Merck tops estimates, hikes profit outlook on strength of injectable Keytruda8 days ago
Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand9 days ago
GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers9 days ago
Measles resurgence exposes deeper weaknesses in U.S. public health, experts say10 days ago
Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock11 days ago
Amgen says drug combo slashes risk of death by 58% in patients with lung cancer11 days ago
Doctors call Moderna, Merck's cancer vaccine data a major advancement14 days ago
Moderna shares plunge after cancer vaccine data leaks — despite positive results15 days ago
New bipartisan bill aims to speed up clinical trials for rare disease treatments16 days ago
Novo's CagriSema obesity drug shows 25% weight loss in women in analysis16 days ago
Sickle cell gene therapies offer new hope, but access remains a major challenge22 days ago
Here's our monthly update on our 32 stocks, including 2 more names to buy22 days ago
Merck CEO tells CNBC he expects cancer vaccine will get faster to make over time22 days ago
What Maven CEO Kate Ryder tells her kids every day amid AI education threat23 days ago
Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost23 days ago
UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs24 days ago
Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock25 days ago